Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-26, Stock:JNJ, The news for the past five days is as follows:
2018-07-19: NEWS1: Johnson & Johnson and General Motors: Growth and Income Stocks.NEWS2: Johnson & Johnson and General Motors: Growth and Income Stocks.NEWS3: These 2 Healthcare Giants Had Diverging Short-Term Moves, but Have Parallel Long-Term Stories.NEWS4: These 2 Healthcare Giants Had Diverging Short-Term Moves, but Have Parallel Long-Term Stories.NEWS5: Women who sued J&J declare victory after $4.69 billion talc verdict.NEWS6: Johnson & Johnson and General Motors: Growth and Income Stocks.NEWS7: Women who sued J&J declare victory after $4.69 bln talc verdict.NEWS8: These 2 Healthcare Giants Had Diverging Short-Term Moves, but Have Parallel Long-Term Stories.NEWS9: Edited Transcript of JNJ earnings conference call or presentation 17-Jul-18 12:30pm GMT.NEWS10: Should Investors Be Worried About Netflix, United Health, or Johnson & Johnson?.NEWS11: Should Investors Be Worried About Netflix, United Health, or Johnson & Johnson?.NEWS12: AbbVie shares drop 5.5% after short seller Citron calls it &apos;next great drug short&apos;.NEWS13: Should Investors Be Worried About Netflix, United Health, or Johnson & Johnson?.NEWS14: Free Research Report as Johnson & Johnson's Quarterly Earnings Advanced 14.75%.NEWS15: New Drugs and Expected Growth Could Trigger a Recovery for Celgene Stock.NEWS16: J&J's Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod.NEWS17: J&J's Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod.NEWS18: Interpublic's Weber Shandwick Acquires Social Agency That Lot.NEWS19: Interpublic's Weber Shandwick Acquires Social Agency That Lot.
2018-07-20: NEWS1: Analysts’ Estimates and Recommendations for Allergan on July 19.NEWS2: MARKETS: Honeywell stock pops after raising full year guidance.NEWS3: 3 Stocks That Could Be Added to the Dow Next.NEWS4: 3 Stocks That Could Be Added to the Dow Next.NEWS5: Dow 30 Stock Roundup: Goldman Sachs, IBM, J&J, Microsoft Earnings Impress.NEWS6: Dow 30 Stock Roundup: Goldman Sachs, IBM, J&J, Microsoft Earnings Impress.NEWS7: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals.NEWS8: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals.NEWS9: 3 Stocks That Could Be Added to the Dow Next.NEWS10: Pharma Stock Roundup: JNJ & NVS&apos; Q2 Earnings, FDA Approvals.NEWS11: Dow 30 Stock Roundup: Goldman Sachs, IBM, J&J, Microsoft Earnings Impress.NEWS12: Three Key Takeaways From Healthcare Earnings Season.NEWS13: Women who sued Johnson & Johnson declare victory after $4.69 billion talc verdict.
2018-07-23: NEWS1: Johnson & Johnson Is a Great Company, But Be Patient.NEWS2: Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger.NEWS3: Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger.NEWS4: MARKETS: Why Trump is talking down bonds and the dollar, but stocks are just shrugging.NEWS5: BIIB, LLY Q2 Earnings on Jul 24: Here are the Key Predictions.NEWS6: BIIB, LLY Q2 Earnings on Jul 24: Here are the Key Predictions.NEWS7: Top Analyst Reports for Johnson & Johnson, Nike & Schlumberger.NEWS8: Oncology Portfolio Sales Drove J&J’s Pharmaceuticals Business.NEWS9: Why J&J’s Consumer Business Didn’t Meet Expectations in Q2 2018.
2018-07-24: NEWS1: What to Expect from Edwards Lifesciences’ Q2 2018 Results.NEWS2: Is a Beat in the Cards for AbbVie (ABBV) in Q2 Earnings?.NEWS3: Is a Beat in the Cards for AbbVie (ABBV) in Q2 Earnings?.NEWS4: Is a Beat in the Cards for AbbVie (ABBV) in Q2 Earnings?.NEWS5: Why Most Analysts Are Bullish on Baxter International.NEWS6: Novartis’s Q2 2018 Earnings: Alcon.NEWS7: What Drove Growth for J&J’s Medical Device Business?.NEWS8: Pharma/Biotech Stock Q2 Earnings on Jul 25: GILD, VRTX & GSK.NEWS9: The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, Schlumberger, CSX and Intuitive Surgical.NEWS10: Analysts’ Targets and Recommendations for Amgen Stock.NEWS11: J&J’s Oncology Franchise Saw 42.2% Growth in Q2 2018.NEWS12: GSK JV ViiV Healthcare Presents Data From Two Phase III Studies.NEWS13: GSK JV ViiV Healthcare Presents Data From Two Phase III Studies.
2018-07-25: NEWS1: 3 Great Stocks for Retirees to Own.NEWS2: Understanding the Components and the Concept of Alpha.NEWS3: Understanding the Components and the Concept of Alpha.NEWS4: Why Most Analysts Are Bullish on NovoCure.NEWS5: Thermo Fisher’s Q2 2018 Earnings Surpass Analysts’ Estimates.NEWS6: Understanding the Components and the Concept of Alpha.NEWS7: SPDR Portfolio S&P 500 Growth ETF Experiences Big Inflow.NEWS8: SPDR Portfolio S&P 500 Growth ETF Experiences Big Inflow.NEWS9: Pfizer to Build Sterile Injectable Facility in Michigan.NEWS10: The Top 4 UPS Shareholders (UPS).NEWS11: Estimates and Recommendations for Thermo Fisher on July 24.NEWS12: Did This Top Biotech Stock Just Go on Sale?.NEWS13: Did This Top Biotech Stock Just Go on Sale?.NEWS14: Thermo Fisher’s Q2 2018 Estimates: Revenue Growth Expected.NEWS15: Novartis’s Valuation after Its Q2 2018 Earnings.NEWS16: Did This Top Biotech Stock Just Go on Sale?.

Answer: Rise